TomoTherapy sale raises questions
They went public within three months of each other, each with a host of eager investors buying into the promise of their radiation therapy systems. Four years later, one is about to swallow the other. Accuray Inc. of Sunnyvale, Calif., said this month it will purchase TomoTherapy Inc. for about $277 million. (MILWAUKEE JOURNAL SENTINEL, 3/21)
To access this content, you must purchase a Premium membership, or log in if you are a member.
